No preservatives in a new drug?--Zioptan (tafluprost) is a first preservative free prostaglandin analog drug for glaucoma
Tafluprost (Zioptan) was approved by the FDA to help lower increased eye pressure in people suffering from open-angle glaucoma and unlike other prostaglandin analogs--it DOES NOT have a preservative.
Tafluprost (Zioptan) was approved by the FDA to help lower increased eye pressure in people suffering from open-angle glaucoma.
An AACE Against Diabetes has prompted a lot of discussion
Knowing more about how diseases or conditions ar best managed raises the treatment and results bar for clinicians and patients and their families.
An AACE guideline release on diabetes has prompted a lot of discussion
Diabetes multiplies the risk of heart disease and is a leading cause of kidney failure, blindness and stroke. The fight against this killer must be personalized…something which the American Association of Clinical Endocrinologists (AACE) has recognized in their new guidelines (Handelsman, Y, Mechanik, J, Blonde, L, Et al.).
The new guidelines outline specific ways that clinicians can develop a COMPREHENSIVE care plan for diabetes mellitus, and stresses the need to move beyond a simple focus on sugar (glycemic) control. This comprehensive approach is based on strong evidence that diabetes impacts heart and blood vessel (cardiovascular) disease risk, death (mortality) and quality of life.
Importantly, the AACE guidelines recognize that every patient is unique and evidence-based use of technology, treatment and comprehensive lifestyle management will lead to the best (optimal) results or outcomes. The framework of the guidelines is built in an easy to understand question and answer format and covers prevention, education, therapeutic lifestyle changes, goals, sleep and depression as well as risk reduction amongst many key points in the 53-page document.
The Executive summary covered in the first 14 pages could teach any medical student, enhance any clinician and lead many patients to get a comprehensive approach to key dangers of diabetes and address far more than the usual sugar control. Added points cover best use of technology, preventing nerve, heart, kidney, lifestyle changes, high blood sugar in the hospital, fats, risk factors and even often missed difficulties such as depression and sleep-related challenges.
You can see the guidelines at www.aace.com. For families and children at risk for or for those living with diabetes, the guidelines will surely be a pathway to prevention or an organized approach to optimal outcomes that should be embraced by clinicians, patients and their families.